Kian Santang Muliatama Tbk. vs Suparma Tbk. — how do they compare? Kian Santang Muliatama Tbk. trades at Rp214 (market cap 315.19B, 8.5M 24h volume), while Suparma Tbk. trades at Rp172 (market cap 701.15B, 378K 24h volume). The key difference: Suparma Tbk. is far larger — about 2.2× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (8.5M versus 378K). Which is the better fit depends on your goals.
| RGAS | SPMA | |
|---|---|---|
Market Cap | 315.19B | 701.15B |
Volume | 8.5M | 378K |
Lot | 84.96K | 3.78K |
Turnover | 1.82B | 64.09M |
Average Price | 214.14 | 169.54 |
Value | 1.82B | 64.09M |
Indicative Equilibrium Price | 214 | 171 |
Indicative Equilibrium Volume | 893 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →